Does ERTAPENEM Cause Off label use? 372 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 372 reports of Off label use have been filed in association with ERTAPENEM (INVANZ). This represents 9.1% of all adverse event reports for ERTAPENEM.
372
Reports of Off label use with ERTAPENEM
9.1%
of all ERTAPENEM reports
14
Deaths
245
Hospitalizations
How Dangerous Is Off label use From ERTAPENEM?
Of the 372 reports, 14 (3.8%) resulted in death, 245 (65.9%) required hospitalization, and 4 (1.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 372 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Macular degeneration (776)
Product use in unapproved indication (346)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
Therapeutic product effect incomplete (208)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ERTAPENEM Alternatives Have Lower Off label use Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN